Tag: biotechnology

Federal efforts to reschedule cannabis typically are framed as a matter of drug policy, centering on taxation, criminal enforcement, and the plant’s classification under the Controlled Substances Act. Yet, this traditional framing increasingly obscures a deeper regulatory transformation. As a partial shift to Schedule III lowers long-standing barriers to genetic research, cannabis is rapidly entering the agricultural biotechnology era. This scientific leap is setting up an unprecedented collision with an unsettled federal oversight landscape. Regulators must now confront whether advanced cannabis innovations will be governed solely as controlled substances or treated as genetically modified crops subject to complex agricultural pest risk oversight.

MELBOURNE, Fla. -- Branded Legacy, Inc (OTC.PK: BLEG), Branded Legacy Inc., a leading name in the biotech industry, takes a giant leap forward with a substantial...

MELBOURNE, Fla. -- Branded Legacy, Inc (OTC.PK: BLEG), an emerging biotechnology company, is excited to announce a strategic partnership with Novus Acquisition & Development Corp...

CAPE TOWN, South Africa -- Institute of Biomedical Research Corp. (OTC-PINK: MRES) ("Institute of Biomedical Research" or the "Company"), a nutraceutical biotechnology company focused on...

HOUSTON and PUEBLO, Colo. -- Vyripharm Enterprises, Inc. and CSU Pueblo announced today a partnership to support the creation of a comprehensive testing and...

DENVER - Dr. Michele Ross, neuroscientist, author and cannabinoid medicine leader, has joined the advisory board for NanoSphere Health Sciences, LLC (CSE: NSHS) (OTC: NSHSF), the...

DENVER–Biotechnology firm NanoSphere Health Sciences, LLC, has announced that they have received a patent for their proprietary NanoSphere Delivery System™, a non-invasive delivery technology...